TrialJournal of neurology2021
Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension.
Joakim Bergman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
TrialJournal of neurology2021
Joakim Bergman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.